Green Scientific Labs Holdings (XCNQ:GSL) Return-on-Tangible-Equity: 0.00% (As of Mar. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Green Scientific Labs Holdings Return-on-Tangible-Equity?

Green Scientific Labs Holdings XCNQ:GSL Return-on-Tangible-Equity is 0.00% as of Mar. 2023.

Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Green Scientific Labs Holdings's annualized net income for the quarter that ended in Mar. 2023 was C$-4.55 Mil. Green Scientific Labs Holdings's average shareholder tangible equity for the quarter that ended in Mar. 2023 was C$-0.97 Mil. Therefore, Green Scientific Labs Holdings's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2023 was N/A%.

The historical rank and industry rank for Green Scientific Labs Holdings's Return-on-Tangible-Equity or its related term are showing as below:

XCNQ:GSL's Return-on-Tangible-Equity is not ranked *
in the Drug Manufacturers industry.
Industry Median: 7.785
* Ranked among companies with meaningful Return-on-Tangible-Equity only.

Green Scientific Labs Holdings  (XCNQ:GSL) Return-on-Tangible-Equity Explanation

Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.


Be Aware

Net Income is used.

Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.


Green Scientific Labs Holdings Return-on-Tangible-Equity Related Terms


Green Scientific Labs Holdings Return-on-Tangible-Equity Historical Data

* Premium members only.

The historical data trend for Green Scientific Labs Holdings's Return-on-Tangible-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Green Scientific Labs Holdings Return-on-Tangible-Equity Chart

Green Scientific Labs Holdings Annual Data
Trend Apr20 Apr21 Dec22
Return-on-Tangible-Equity
0.00 0.00 0.00

Green Scientific Labs Holdings Quarterly Data
Jan20 Apr20 Jul20 Jan21 Apr21 Jul21 Oct21 Mar22 Jun22 Sep22 Dec22 Mar23
Return-on-Tangible-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -107.69 -87.64 -170.05 -980.93 0.00

XCNQ:GSL vs ZTS: Return-on-Tangible-Equity Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Green Scientific Labs Holdings's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Green Scientific Labs Holdings Return-on-Tangible-Equity vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Green Scientific Labs Holdings's Return-on-Tangible-Equity distribution charts can be found below:

* The bar in red indicates where Green Scientific Labs Holdings's Return-on-Tangible-Equity falls into.



Green Scientific Labs Holdings Return-on-Tangible-Equity Calculation

Green Scientific Labs Holdings's annualized Return-on-Tangible-Equity for the fiscal year that ended in Dec. 2022 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(A: Dec. 2022 )  (A: Apr. 2021 )(A: Dec. 2022 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets )/ count )
(A: Dec. 2022 )  (A: Apr. 2021 )(A: Dec. 2022 )
=-13.362/( (-1+-0.426 )/ 2 )
=-13.362/-0.713
=N/A %

Green Scientific Labs Holdings's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2023 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(Q: Mar. 2023 )  (Q: Dec. 2022 )(Q: Mar. 2023 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets)/ count )
(Q: Mar. 2023 )  (Q: Dec. 2022 )(Q: Mar. 2023 )
=-4.548/( (-0.426+-1.505)/ 2 )
=-4.548/-0.9655
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Mar. 2023) net income data. Return-on-Tangible-Equity is displayed in the 10-year financial page.

What does a Return-on-Tangible-Equity of 0.00% mean?
Green Scientific Labs Holdings (XCNQ:GSL) has a Return-on-Tangible-Equity of 0.00% as of Mar. 2023. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Green Scientific Labs Holdings and its competitors.
Is Green Scientific Labs Holdings' Return-on-Tangible-Equity too high?
Green Scientific Labs Holdings' current Return-on-Tangible-Equity is 0.00%.
How does Green Scientific Labs Holdings' Return-on-Tangible-Equity compare to ZTS?
Green Scientific Labs Holdings' Return-on-Tangible-Equity of 0.00% can be compared against companies in the Drug Manufacturers industry. The industry median Return-on-Tangible-Equity is 7.79. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Drug Manufacturers company?
The median Return-on-Tangible-Equity among Drug Manufacturers companies is 7.79, based on 894 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Green Scientific Labs Holdings and its competitors. For the Drug Manufacturers industry, the median Return-on-Tangible-Equity is 7.79 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Green Scientific Labs Holdings's current Return-on-Tangible-Equity is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Green Scientific Labs Holdings stock overvalued right now?
Green Scientific Labs Holdings (XCNQ:GSL) has a current Return-on-Tangible-Equity of 0.00%. The current Return-on-Tangible-Equity is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Green Scientific Labs Holdings (XCNQ:GSL), the current Return-on-Tangible-Equity is 0.00% as of Mar. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Green Scientific Labs Holdings Business Description

Address 4001 SW 47th Avenue, Suite 208, Davie, FL, USA, 33314
Green Scientific Labs Holdings Inc is a cannabis and hemp testing laboratory that operates a Certified Marijuana Testing Laboratory licensed testing lab facility. The Company provides analytical testing services including tests for cannabinoid content (potency), terpene content, water activity, moisture content, pesticides, residual solvents, heavy metals, filth and foreign material, and microbiological contaminants for state-licensed cannabis and hemp growers, product formulators, processors, distributors, and retailers. The Company operates in the Geographical regions of Florida and Arizona in the United States.